BioLargo, Inc.
BLGO · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $56,643 | $48,032 | $52,292 | $51,913 |
| - Cash | $3,548 | $3,539 | $1,851 | $962 |
| + Debt | $2,554 | $1,698 | $1,468 | $1,133 |
| Enterprise Value | $55,649 | $46,191 | $51,909 | $52,084 |
| Revenue | $17,779 | $12,230 | $5,884 | $2,531 |
| % Growth | 45.4% | 107.9% | 132.5% | – |
| Gross Profit | $7,853 | $6,154 | $2,857 | $1,103 |
| % Margin | 44.2% | 50.3% | 48.6% | 43.6% |
| EBITDA | -$4,059 | -$4,186 | -$5,097 | -$6,703 |
| % Margin | -22.8% | -34.2% | -86.6% | -264.8% |
| Net Income | -$2,402 | -$3,504 | -$4,496 | -$7,377 |
| % Margin | -13.5% | -28.7% | -76.4% | -291.5% |
| EPS Diluted | -0.008 | -0.012 | -0.017 | -0.03 |
| % Growth | 34.1% | 26.8% | 43.6% | – |
| Operating Cash Flow | -$3,206 | -$2,365 | -$2,762 | -$3,937 |
| Capital Expenditures | -$1,235 | -$478 | -$271 | -$34 |
| Free Cash Flow | -$4,441 | -$2,843 | -$3,033 | -$3,971 |